Navigation Links
Some Face Transplant Patients May Regain Sensory, Motor Function
Date:10/26/2012

FRIDAY, Oct. 26 (HealthDay News) -- Within a year after having face transplant surgery, some patients regain sensory and motor functions such as the ability to speak, chew food and smile, experts have found.

For the study, Dr. Bohdan Pomahac, director of the plastic surgery transplantation program at Brigham & Women's Hospital in Boston, and colleagues assessed the return of sensory and motor functions in four patients who had full or partial face transplants between 2009 and 2011.

Initially, the transplant patients could not breathe through their new mouth or nose and required a breathing tube. They were also unable to speak or chew, and could not sense objects touching the surface of their skin.

But one year after the transplant, some of the patients could breathe, eat and talk quite easily. They also regained their sense of smell, were able to make facial expressions and could do some socializing, the investigators found.

These successes depended on whether major nerves in the body were able to be reconnected with those in the transplanted face, the researchers noted. In some patients, severe damage from their original injuries made it impossible to reconnect nerves in some areas.

The study was scheduled for presentation Saturday at the American Society of Plastic Surgeons' annual meeting in New Orleans.

"What we found is that a face transplant is more than a way to create a more pleasing appearance because the new face can be functional as well," Pomahac, who is also an ASPS member surgeon, said in a society news release.

The data and conclusions of research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

More information

The American Academy of Facial Plastic and Reconstructive Surgery has more about face transplantation.

-- Robert Preidt

SOURCE: American Society of Plastic Surgeons, news release, Oct. 24, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Discovery could help to develop drugs for organ transplant and cancer patients
2. Xenotransplantation as a therapy for type 1 diabetes
3. First, Second Kidney Transplants Have Similar Success: Study
4. Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
5. Statins prevent cancer in heart transplant recipients
6. U.S. Liver Transplants Declining
7. Study shows antibiotic improves respiratory function in lung transplant patients
8. UCLA launches first face transplantation program in western US
9. Use of Smokers Lungs for Transplant Has Pros, Cons
10. Skin transplant offers new hope for vitiligo patients
11. Haematopoietic stem cell transplantation increases survival in systemic sclerosis patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Some Face Transplant Patients May Regain Sensory, Motor Function 
(Date:3/29/2017)... ... March 29, 2017 , ... Dr. Angela Cotey, a noted general ... accepting new pediatric patients, with or without a referral. Dr. Cotey knows that ... orthodontic outcome and experience. When patients receive early treatment, they may achieve straight teeth ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... buildings (MOBs) and other outpatient facilities, and who are the most active developers? ... those questions, Revista and Healthcare Real Estate Insights (HREI) found that outpatient medical ...
(Date:3/29/2017)... ... , ... Curio Wellness , a premium medical cannabis brand and trusted ... management team with prominent executives from both inside and outside the cannabis industry. ... Ted Dumbauld , who has more than twenty years of business leadership and investment ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an important webinar ... at 1:00 PM ET. A recording of the webinar will also be made available ... Home health and hospice companies are still popular targets for healthcare investors. This highly ...
(Date:3/29/2017)... ... 2017 , ... Immunotherapy has emerged as one of the most promising options ... be the next revolution in our fight against this complex disease. One of the ... checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Calif. , March 29, 2017  Experts ... recognized remote monitoring devices like  Soberlink Systems  as ... The consensus paper, published in early 2017, concluded ... and valuable in managing patient recovery." ... the Journal of Addiction Medicine, detail a range ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, ... for GSP 301, an investigational fixed-dose combination of ... mcg) administered twice-daily as a nasal spray being ... These results are from a recently completed Phase ... GSP 301 combination therapy versus mometasone, olopatadine or ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and ... Market 2017-2021" report to their offering. ... The global lifestyle drugs market to ... The report, Global Lifestyle Drugs Market 2017-2021, has been ... experts. The report covers the market landscape and its growth prospects ...
Breaking Medicine Technology: